GETI-B.ST — Getinge

Health Care · Nasdaq Stockholm. Last price 276.80 SEK (-1.14% on the day). Raven's AI 12-month target: 310.00 SEK. Updated 2026-11-20.

Paper-trade Getinge free with 100 000 fake NOK and compete with other players on Raven Trading Game.

Raven’s AI view

Raven's AI sets a 12-month target of 310.00 SEK (+10.71% from 280.00 when it was set on 2026-11-20). Conviction: medium.

Catalysts: Healthcare capex cycle upturn in Nordics; Product launches in surgical equipment; Aging demographic tailwind in Europe

Risks: Healthcare budget pressures in key markets; Competitive pricing dynamics; Supply chain or integration delays

Earnings

Q3 2026 earnings per share: 3.10 SEK against 2.63 expected (beat by 18.0%). EPS estimates for 2026: 13.26 SEK (11 analysts), 2027: 14.63 SEK (11 analysts). The 2026 estimate has moved +5.0% over 90 days.

Dividends

Getinge has paid 4.75 SEK per share in dividends over the last 12 months (1.7% yield). Last dividend: 4.75 SEK per share, ex-dividend 2026-04-22.

Home · All shares · Leaderboard · News · Learn: stock market courses · AI insights · Raven bot · DNB Markets bot · Mistral bot · Maven bot

More Health Care stocks on Nasdaq Stockholm: AZN AstraZeneca · SOBI Sobi

RAVEN is taking longer than usual to load.
RELOAD